Hearing loss in vestibular schwannoma
Abstract Purpose: The most common reason for consultation in patients suffering from Vestibular Schwannoma (VS) is progressive hearing loss. The main objective of this study is analyzing the hearing loss in patients with VS and determining the extent to which the tumor grade and the hearing loss are related. Methods: An observational retrospective study was conducted with a sample of 291 patients diagnosed with VS between 1995 and 2017 in the Department of Otorhinolaryngology and Head and Neck Surgery of the Tertiary Care Primary Center of Salamanca. We analyzed preoperative and postoperative data from patients with VS as well as radiological and surgical findings. Results: The most common reason for consultation at diagnosis was progressive unilateral hearing loss (31.6%). The relationship between the size of the VS and hearing loss in the patients who reported progressive unilateral hearing loss as a reason for consultation was not statistically significant (p=0.099). Conclusion: The most common reason for consultation in VS is progressive unilateral hearing loss. The hearing loss caused by VS does not have a statistically significant association with any particular tumor grade, although severe and profound hearing loss is more commonly associated with grade III-IV neurinomas, whereas mild hearing loss or normal hearing are more likely in grade I-II tumors.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Komatsuzaki A, Tsunoda A. Nerve origin of the acoustic neuroma. J Laryngol Otol. 2001; 115(5): 376-9. doi: 10.1258/0022215011907910
Khrais T, Romano G, Sanna M. Nerve origin of vestibular schwannoma: a prospective study. J Laryngol Otol. 2007; 122: 128-31. doi: 10.1017/S0022215107001028
Stott C, Albertz N, Aedo C. Neurinoma del acústico: revisión y actualización de la literatura. Rev Otorrinolaringol Cir Cabeza Cuello. 2008; 68(3): 301-8. doi: 10.4067/S0718-48162008000400012
Chen DA. Acoustic neuroma in a private neurotology practice: trends in demographics and practice patterns. Laryngoscope. 2007; 117(11): 2003-12. doi: 10.1097/MLG.0b013e3181373876
Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas. Laryngoscope. 1999; 109(5): 736-40. doi: 10.1097/00005537-199905000-00011
Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol. 2006; 27(4): 547–52. doi: 10.1097/01.mao.0000217356.73463.e7
Charabi S, Thomsen J, Tos M, Charabi B, Mantoni M, Borgesen SE. Acoustic neuroma: vestibular schwannoma growth: past, present and future. Acta Otolaryngol. 1998; 118: 327-32. doi: 10.1016/s0194-5998(95)70138-9
Evans DR. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009; 4(1): 16. doi: 10.1186/1750-1172-4-16
Dazert S, Aletsee C, Brors D, Mlynski R, Sudhoff H, Hildmann H, Helms J. Rare tumors of the internal auditory canal. Eur Arch Otorhinolaryngol. 2005; 262(7): 550-4. doi: 10.1007/s00405-003-0734-4
Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg. 2006; 105(4): 527-35. doi: 10.3171/jns.2006.105.4.527
Benett M, Haynet DS. Surgical approaches and complications in the removal of vestibular schwannomas. Otolaryngol Clin North Am. 2007; 40(3): 589-609. doi: 10.1016/j.otc.2007.03.007
Ebersold MJ, Harner SG, Beatty CW, Harper CM, Quast LM. Current results of the retrosigmoid approach to acoustic neuroma. J Neurosurg. 1992; 76(6): 901-9. doi: 10.3171/jns.1992.76.6.0901
Lassaletta L, Gavilán J. An update on the treatment of vestibular schwannoma. Acta Otorrinolaringol Esp. 2009; 60:131-40. doi: 10.1016/S2173-5735(09)70116-4
Matthies C, Samii M. Management of 1000 Vestibular Schwannomas (Acoustic Neuromas): Clinical Presentation. Neurosurg. 1997; 40 (1): 1–10. doi: 10.1097/00006123-199701000-00002
Marcos Alonso S, Villaoslada Fuentes R, Martínez Carranza R, Santacruz Ruiz S, Muñoz Herrera Á, Batuecas Caletrío A. Cirugía del Schwannoma Vestibular. Factores predisponentes y predictores de parálisis facial. Rev ORL. 2019; 10(3). doi: 10.14201/orl.20152
Gupta VK, Thakker A, Gupta KK. Vestibular Schwannoma: What We Know and Where We are Heading. Head Neck Pathol. 2020 Dec;14(4):1058-1066. doi: 10.1007/s12105-020-01155-x
de Saint Victor SM, Bonnard D, Darrouzet V, Bellec O, Franco-Vidal V. Stage II vestibular schwannoma: predictive factors for postoperative hearing loss and facial palsy. Eur Ann Otorhinolaryngol Head Neck Dis. 2012; 129(2): 87-92. doi: 10.1016/j.anorl.2011.09.001
Fernández Cascón S, Fernández Morais R, Álvarez Otero R. Revisión sobre la importancia clínica del nistagmo espontáneo y de la prueba de agitación cefálica. Rev ORL. 2018; 9(2): 111-9. doi: 10.14201/orl.17173
Xu F, Pan S, Alonso F, Dekker SE, Bambakidis NC., Intracranial facial nerve schwannomas: current management and review of literature. World Neurosurg. 2017; 100: 444-9. doi: 10.1016/j.wneu.2016.09.082
Paldor I, Chen AS, Kaye AH. Growth rate of vestibular schwannoma. J Clin Neurosci. 2016; 32:1-8. doi: 10.1016/j.jocn.2016.05.003
Stott C, Albertz N, Aedo C. Neurinoma del acústico (schwanoma vestibular): Revisión y actualización de la literatura. Rev. Otorrinolaringol. Cir. Cabeza Cuello. 2008; 68(3). doi: 10.4067/S0718-48162008000400012
Sauvaget E, Kici S, Kania R, Hermán P, Tran BA, Huy P. Sudden sensorineural Hearing loss as a revealing symptom of vestibular Schwannoma. Acta Otolaryngol. 2005; 125: 592-5. doi: 10.1080/00016480510030246
Inoue Y, Kanzaki J, Ogawa K. Vestibular schwannoma presenting as sudden deafness. J Laryngol Otol. 2000; 114: 589-92. doi: 10.1258/0022215001906471
Blanco EC, Herrera ÁM, López JMS, Sánchez ÁM, Escudero JCP. Caracterización clínica del schwannoma del VIII par. ¿Son suficientemente expresivos sus síntomas? Acta Otorrinolaringol Esp. 2008; 58(2), 43-47. doi: 10.1016/S0001-6519(07)74877-X
Beck J, Beatty C, Harner S, Ilstrup D. Acoustic neuromas with normal pure tone hearing level. Otolaryngol Head Neck Surg. 1986;94:96-103. doi: 10.1177/019459988609400116
Selesnick S, Jackler R, Pitts L. The changing clinical presentation of acoustic tumors in the MRI era. Laryngoscope. 1993;103:431-6. doi: 10.1002/lary.5541030412
Beck JH, Beatty CW, Harner SG, Ilstrup DM. Acoustic neuromas with normal pure tone hearing level. Otolaryngol Head Neck Surg. 1986. 94:96-103. doi: 10.1177/019459988609400116
Kentala E, Pyykkö I. Clinical picture of vestibular schwannoma. Auris Nasus Larynx. 2001 Jan 1;28(1):15-22. doi: 10.1016/S0385-8146(00)00093-6
Del Rio L, Lassaletta L, Alfonso C, Sarria MJ, Gavilán J. Disociación clínica-tamaño tumoral en el neurinoma del acústico: ¿realidad o problema de medida? Acta Otorrinolaringol Esp. 2006; 57: 345-49. doi: 10.1016/S0001-6519(06)78725-8
Sauvaget E, Kici S, Kania R, Herman P, Tran Ba Huy P. Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma. Acta Oto-Laryngologica Scandinavica. 2005;125:592-595. doi: 10.1080/00016480510030246
Thierney PA, Chitnavis BP, Sherriff M et al. The relationship between pure tone thresholds and the radiological dimensions of acoustic neuromas. Skull Base Surg 1998;8:149-51. doi: 10.1055/s-2008-1058574
Couloigner V, Gervaz E, Kalamarides M, Ferrary E, Rey A, Sterkers O, et al. Clinical and histologic parameters correlated with facial nerve function after vestibular schwannoma surgery. Skull Base. 2003;13:13-19. doi: 10.1055/s-2003-820553
Forton G, Cremers W, Offeciers F. Acoustic neuroma ingrowth in the cochlear nerve: does it influence the clinical presentation? Ann Otol Rhinol Laryngol 2004;113:582-86. doi: 10.1177/000348940411300713
Khrais T, Romano G, Sanna M. Nerve origin of vestibular schwannoma: a prospective study. J Laryngol Otol. 2007; 122: 128-31. doi: 10.1017/S0022215107001028
Stott C, Albertz N, Aedo C. Neurinoma del acústico: revisión y actualización de la literatura. Rev Otorrinolaringol Cir Cabeza Cuello. 2008; 68(3): 301-8. doi: 10.4067/S0718-48162008000400012
Chen DA. Acoustic neuroma in a private neurotology practice: trends in demographics and practice patterns. Laryngoscope. 2007; 117(11): 2003-12. doi: 10.1097/MLG.0b013e3181373876
Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas. Laryngoscope. 1999; 109(5): 736-40. doi: 10.1097/00005537-199905000-00011
Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol. 2006; 27(4): 547–52. doi: 10.1097/01.mao.0000217356.73463.e7
Charabi S, Thomsen J, Tos M, Charabi B, Mantoni M, Borgesen SE. Acoustic neuroma: vestibular schwannoma growth: past, present and future. Acta Otolaryngol. 1998; 118: 327-32. doi: 10.1016/s0194-5998(95)70138-9
Evans DR. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009; 4(1): 16. doi: 10.1186/1750-1172-4-16
Dazert S, Aletsee C, Brors D, Mlynski R, Sudhoff H, Hildmann H, Helms J. Rare tumors of the internal auditory canal. Eur Arch Otorhinolaryngol. 2005; 262(7): 550-4. doi: 10.1007/s00405-003-0734-4
Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg. 2006; 105(4): 527-35. doi: 10.3171/jns.2006.105.4.527
Benett M, Haynet DS. Surgical approaches and complications in the removal of vestibular schwannomas. Otolaryngol Clin North Am. 2007; 40(3): 589-609. doi: 10.1016/j.otc.2007.03.007
Ebersold MJ, Harner SG, Beatty CW, Harper CM, Quast LM. Current results of the retrosigmoid approach to acoustic neuroma. J Neurosurg. 1992; 76(6): 901-9. doi: 10.3171/jns.1992.76.6.0901
Lassaletta L, Gavilán J. An update on the treatment of vestibular schwannoma. Acta Otorrinolaringol Esp. 2009; 60:131-40. doi: 10.1016/S2173-5735(09)70116-4
Matthies C, Samii M. Management of 1000 Vestibular Schwannomas (Acoustic Neuromas): Clinical Presentation. Neurosurg. 1997; 40 (1): 1–10. doi: 10.1097/00006123-199701000-00002
Marcos Alonso S, Villaoslada Fuentes R, Martínez Carranza R, Santacruz Ruiz S, Muñoz Herrera Á, Batuecas Caletrío A. Cirugía del Schwannoma Vestibular. Factores predisponentes y predictores de parálisis facial. Rev ORL. 2019; 10(3). doi: 10.14201/orl.20152
Gupta VK, Thakker A, Gupta KK. Vestibular Schwannoma: What We Know and Where We are Heading. Head Neck Pathol. 2020 Dec;14(4):1058-1066. doi: 10.1007/s12105-020-01155-x
de Saint Victor SM, Bonnard D, Darrouzet V, Bellec O, Franco-Vidal V. Stage II vestibular schwannoma: predictive factors for postoperative hearing loss and facial palsy. Eur Ann Otorhinolaryngol Head Neck Dis. 2012; 129(2): 87-92. doi: 10.1016/j.anorl.2011.09.001
Fernández Cascón S, Fernández Morais R, Álvarez Otero R. Revisión sobre la importancia clínica del nistagmo espontáneo y de la prueba de agitación cefálica. Rev ORL. 2018; 9(2): 111-9. doi: 10.14201/orl.17173
Xu F, Pan S, Alonso F, Dekker SE, Bambakidis NC., Intracranial facial nerve schwannomas: current management and review of literature. World Neurosurg. 2017; 100: 444-9. doi: 10.1016/j.wneu.2016.09.082
Paldor I, Chen AS, Kaye AH. Growth rate of vestibular schwannoma. J Clin Neurosci. 2016; 32:1-8. doi: 10.1016/j.jocn.2016.05.003
Stott C, Albertz N, Aedo C. Neurinoma del acústico (schwanoma vestibular): Revisión y actualización de la literatura. Rev. Otorrinolaringol. Cir. Cabeza Cuello. 2008; 68(3). doi: 10.4067/S0718-48162008000400012
Sauvaget E, Kici S, Kania R, Hermán P, Tran BA, Huy P. Sudden sensorineural Hearing loss as a revealing symptom of vestibular Schwannoma. Acta Otolaryngol. 2005; 125: 592-5. doi: 10.1080/00016480510030246
Inoue Y, Kanzaki J, Ogawa K. Vestibular schwannoma presenting as sudden deafness. J Laryngol Otol. 2000; 114: 589-92. doi: 10.1258/0022215001906471
Blanco EC, Herrera ÁM, López JMS, Sánchez ÁM, Escudero JCP. Caracterización clínica del schwannoma del VIII par. ¿Son suficientemente expresivos sus síntomas? Acta Otorrinolaringol Esp. 2008; 58(2), 43-47. doi: 10.1016/S0001-6519(07)74877-X
Beck J, Beatty C, Harner S, Ilstrup D. Acoustic neuromas with normal pure tone hearing level. Otolaryngol Head Neck Surg. 1986;94:96-103. doi: 10.1177/019459988609400116
Selesnick S, Jackler R, Pitts L. The changing clinical presentation of acoustic tumors in the MRI era. Laryngoscope. 1993;103:431-6. doi: 10.1002/lary.5541030412
Beck JH, Beatty CW, Harner SG, Ilstrup DM. Acoustic neuromas with normal pure tone hearing level. Otolaryngol Head Neck Surg. 1986. 94:96-103. doi: 10.1177/019459988609400116
Kentala E, Pyykkö I. Clinical picture of vestibular schwannoma. Auris Nasus Larynx. 2001 Jan 1;28(1):15-22. doi: 10.1016/S0385-8146(00)00093-6
Del Rio L, Lassaletta L, Alfonso C, Sarria MJ, Gavilán J. Disociación clínica-tamaño tumoral en el neurinoma del acústico: ¿realidad o problema de medida? Acta Otorrinolaringol Esp. 2006; 57: 345-49. doi: 10.1016/S0001-6519(06)78725-8
Sauvaget E, Kici S, Kania R, Herman P, Tran Ba Huy P. Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma. Acta Oto-Laryngologica Scandinavica. 2005;125:592-595. doi: 10.1080/00016480510030246
Thierney PA, Chitnavis BP, Sherriff M et al. The relationship between pure tone thresholds and the radiological dimensions of acoustic neuromas. Skull Base Surg 1998;8:149-51. doi: 10.1055/s-2008-1058574
Couloigner V, Gervaz E, Kalamarides M, Ferrary E, Rey A, Sterkers O, et al. Clinical and histologic parameters correlated with facial nerve function after vestibular schwannoma surgery. Skull Base. 2003;13:13-19. doi: 10.1055/s-2003-820553
Forton G, Cremers W, Offeciers F. Acoustic neuroma ingrowth in the cochlear nerve: does it influence the clinical presentation? Ann Otol Rhinol Laryngol 2004;113:582-86. doi: 10.1177/000348940411300713
Marcos Alonso, S., Almeida Ayerve, C. N., Pacheco López, S., Peña Navarro, P., Sánchez Gómez, H., Santa Cruz Ruíz, S., & Batuecas Caletrío, Ángel . (2022). Hearing loss in vestibular schwannoma. Revista ORL, 13(1), e27266. https://doi.org/10.14201/orl.27266
Most read articles by the same author(s)
- Ángel Batuecas-Caletrío, Santiago Santa Cruz Ruiz, José Luis Pardal-Refoyo, Atlas of Otoscopy for Students , Revista ORL: Vol. 13 No. S1 (2022): Atlas of Otoscopy for Students
- Estela Cristina Prieto Maillo, Sofía Ferreira Cendón, María José Fernández Nava, Ramón Antonio Martínez Carranza, José Carlos Gómez Sánchez, Ángel Batuecas Caletrío, Impact of Tinnitus in Patients with Ménière's Disease , Revista ORL: Vol. 12 No. 3 (2021)
- María José Fernández-Nava, Sofía Ferreira Cendón, Sara Alonso de la Iglesia, María de las Mercedes Cecilio Rivas, Ana Belén Alonso San Eloy, Ángel Batuecas Caletrío, Stability limits in different posturography patterns. Cohort study. , Revista ORL: Vol. 13 No. 4 (2022)
- Cristina Villaoslada Fuentes, María José Fernández-Nava, Sofía Ferreira Cendón, Rosana Villaoslada Fuentes, Hortensia Sánchez Gómez, Ángel Batuecas Caletrío, Hearing loss after intratympanic gentamicin in Ménière's disease. Retrospective study , Revista ORL: Vol. 12 No. 3 (2021)
- Rosana Villaoslada Fuentes, Ramón Antonio Martinez Carranza, Santiago Santa Cruz Ruiz, María Marco Carmona, Gabriel Castillo Varela, Gianni Mercy García Núñez, Revisión de Cirugía de Otosclerosis en Hospital Clínico de Salamanca desde 2016 a 2017 , Revista ORL: Segovia 2018
- HORTENSIA Sánchez Gómez, ÁNGEL Batuecas Caletrío, FERNANDO Benito González, DETECCIÓN PRECOZ DE HIPOACUSIA EN RECIÉN NACIDOS EN LA PROVINCIA DE SALAMANCA , Revista ORL: SORIA 2019
- Rosana Villaoslada Fuentes, Emilia Batuecas Ramos, Ángel Batuecas Caletrío, Ramón Antonio Martínez Carranza, MORIR SIN OTORRINOLARINGÓLOGO. Causas de muerte otorrinolaringológicas en una comunidad rural del siglo XIX , Revista ORL: Segovia 2018
- Maria Marco Carmona, Erwin Alejandro Racines Alava, Hortensia Sánchez Gómez, Jean Franco Intraprendente Martini, Pedro Blanco Pérez, MASA CERVICAL EN EL CONTEXTO DE ENFERMEDAD DE MADELUNG. A PROPÓSITO DE UN CASO. , Revista ORL: Segovia 2018
- Ángel Batuecas Caletrío, COLABORATION AS WAY TO SATISFACTION , Revista ORL: Segovia 2018
Downloads
Download data is not yet available.
+
−